alexa Novel Approaches for Chronic Pain | Open Access Journals
ISSN: 2329-9096
International Journal of Physical Medicine & Rehabilitation
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Novel Approaches for Chronic Pain

Areerat Suputtitada*

Faculty of Medicine, Chulalongkorn University & King Chulalongkorn Memorial Hospital, Bangkok, Thailand

*Corresponding Author:
Areerat Suputtitada
Physiatrist, Faculty of Medicine
Chulalongkorn University & King Chulalongkorn Memorial Hospital
Bangkok, Thailand
Tel: 66814888549
E-mail: prof.areerat@gmail.com; sareerat1111@gmail.com

Received Date: May 26, 2016; Accepted Date: June 27, 2016; Published Date: July 04, 2016

Citation: Suputtitada A (2016) Novel Approaches for Chronic Pain. Int J Phys Med Rehabil 4:350. doi: 10.4172/2329-9096.1000350

Copyright: © 2016 Suputtitada A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at International Journal of Physical Medicine & Rehabilitation

Abstract

Chronic pain describes a syndrome lasts for more than 3 months. characterized by persistent physical pain, disability, emotional disturbance, and social withdrawal symptoms, existing together and influencing one another in what Bandura termed reciprocal determinism. If original pain is not treated completely, the repeat pain signals lead to change in the central nervous system becomes hypersensitivity. This is the novel concept of central sensitization for chronic pain. Desensitization of the segment consists of local injection with anaesthetic agents for blocking posterior branch of the dorsal spinal nerve along the related paraspinal muscles, together with local anaesthetic injection directly to the trigger points, Extracorporeal Shock Wave Therapy (ESWT) and High intensity laser therapy for desensitization of trigger point foci and area of sensitization. All are novel therapies for chronic pain.

Keywords

Chronic pain; Central sensitization; Desensitization; ESWT; HILT; Diagnostic ultrasound

Introduction

‘Chronic pain' describes a syndrome lasts for more than 3 months [1]. Chronic pain management is challenge since complex etiology and inadequately treatment. The duration of ongoing pain is not only the diagnostic criteria. Some physicians advise that any pain that persists longer than the expected healing time for the pathological tissues could be considered as chronic pain [2,3]. “Biopsychosocial systems model” is used for management of chronic pain patients [4]. With the novel of MRI imaging for demonstration of brain area which is activated by stimuli, the pain effect on emotion and the emotion effect on pain can be revealed.

The recently understanding of "central sensitization” is as if initial pain from an injury is not adequately treated, those pain signals are repeatedly sent, which leads to changes in the central nervous system, making it hypersensitive. Sensitization of spinal segments is the main cause of continuous hypersensitive pain in the associated part of the body. The recent concept of chronic pain is the sensitization of spinal nociceptive neurons, with or without the original provoking stimuli. The clinical presentation of dorsal horn sensitization is including dermatomal hyperalgesia, sclerotome pressure pain sensitivity and myotome myofascial trigger points, which are all supplied by the sensitized spinal segment. There is significant elevation of the levels of nociceptive pain substances as substance P serotonin, and norepinephrine, calcitonin gene-related peptide (CGRP), bradykinin, tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the area of active myofascial trigger point. There is significantly low pH in the active trigger point. Chronic pain management need to concern all these information, especially in chronic patients with amplified pain responses. The segmental sensitization consists of the nociceptive stimuli in the sensitized areas with sending the sensitization signal to bombard the dorsal horn in the spinal cord. This causes central nervous system sensitization with resulting of dermatomal and sclerotome hyperalgesia and spreading from the sensory component of the spinal segment to the anterior horn cells, which control the myotome resulting of myotome myofascial trigger points within the territory of the segmental sensitization [5-10].

The segmental desensitization treatment consists of injection of local anaesthetic agents in the involved dermatome to block the posterior branch of the dorsal spinal nerve along the involved paraspinal muscles. Certainly, local injection with anaesthetic agents is applied peripherally directly into myofascial trigger points. Stretching exercises, local heat application and additional transcutaneous electrical nerve stimulation (TENS) treatment will completely relax the muscles after the injections.

Extracorporeal Shock Wave Therapy (ESWT) also plays a role as desensitization [10-12]. Extracorporeal Shock Wave Therapy (ESWT) can be nowadays approved as an effective, safe, noninvasive therapy for many musculoskeletal diseases and many conditions where regenerative effects are desirable. It is the novel therapy for applications in the fields of regenerative medicine, tissue engineering and cell therapies [11-14].

ESWT consists of biphasic acoustic energy that arises from positive high peak pressures to negative phase with the short rising times and short duration. The generation of focused and radial shockwaves are different. The focused shock waves will generate single acoustic pulses by electrohydraulic principle, electromagnetic principle or piezoelectric principle. The acoustic pulses are converted into a focused acoustic pressure wave with the highest pressure at the target pathological tissue. The radial shock waves will generate a projectile pressure wave within a guiding tube that attacks a metal applicator targeted on the pathological tissue. The energy of focused shock waves decreased within the target tissue consists of bone, calcifications, water, etc., more than 50% in occasionally, whereas consistent energy flux density was found in radial shock wave [12-14].

Shock waves effect on soft tissue and musculoskeletal tissue are as the follows; (1) increase cell membrane permeability and microscopic circulation of tissues which enhance the metabolism, healing and dissolution of calcification; (2) cavitation bubbles which are the result of high pressure energy wave will expand to a maximum size, then collapse, like a bubble popping creating the high force for breaking down the calcification deposit in soft tissues; (3) the micro jets which are the smaller secondary energy force after cavitation bubbles collapse also breaks down the calcification; (4) thousands of cavitation bubbles formed from several thousand shockwaves being treated at the injured tissues cans breakdown calcification deposit in joints, soft tissues and spur; (5) enhance the healing process of bone by stimulation of osteoblasts; (6) enhance the healing process of connective tissues such as tendon, ligaments, and fascia by stimulation of ESWT has also been shown to stimulate fibroblasts [13,14].

In myofascial fascial pain syndrome, the mechano-transduction effect of ESWT may increase perfusion and promote angiogenesis. Moreover, there are evidences of free nerve endings degeneration and transient dysfunction of nerve excitability at the neuromuscular junction, a pure mechanism of breaking-up the actin myosin links with the overstimulation lead to a diminished transmission of pain signals to the brainstem. For pain transmission, in animal studies revealed substance P, calcitonin gene-related peptide (CGRP) expression in the dorsal root ganglion and on neurovascular sprouting [12-22].

There are evidences of improving motor dysfunction, slower the joint degeneration and amelioration of pain in osteoarthritis by ESWT. The mechanisms are as (1) Inhibition of nitric oxide production in knee synovia and reduce chondrocyte apoptosis; (2) Reduction of cartilage degradation biomarkers as shown in Mankin score and Safranin O strain with reduction of matrix metalloproteinase 13 (MMP-13), type II collagen, nitric oxide, DKK-1 (Dickkopf WNT Signaling Pathway Inhibitor; (3) Promote bone healing and tissue repair with ingrowth of neovascularization and upregulation of angiogenic and osteogenic growth factors, such as vessel endothelial growth factor (VEGF), proliferating cell nuclear antigen (PCNA), and bone morphogenetic protein 2 (BMP-2), osteocalcin.

In spastic pain, the mechanism of ESWT in relief of spasticity might be as follows: (1) the generation of nitric oxides play important role in neurotransmission at neuromuscular junction, memories, and synaptic plasticity in the central nervous system; (2) the effect on excitability of the spinal cord; (3) the effect of mechanical vibration; (4) the effect on the Golgi tendon organ; (5) the passive stiffness of muscles determined by inactive connective tissues [12-14].

Established PRM indications are as the follows; Myofascial pain/ trigger points, Tendinopathies, Calcifying tendonitis of the shoulder, Sub acromial pain syndrome, Primary long bicipital tenosynovitis, Tennis elbow (epicondylitis humeralradialis), Golfer‘s elbow, Greater trochanteric pain syndrome, Patellar tendinopathy, Achilles tendinopathy, Plantar fasciopathy, Idiopathic low back pain/ pseudoradicular syndrome, Idiopathic cervical pain, Osgood Schlatter disease, Pseudarthrosis/nonunion. Emerging PRM indications are persisting pain after partial or total joint replacement, primary osteoarthritis, painful neuropathy, secondary lymphedema, spasticity, acute and chronic soft tissue wounds [12-14].

The advantage for treatment with ESWT are as the follows; (1) effectively relieves pain in more than 80 percent of patients even after just three treatments; (2) can replace surgery in many cases of diseases of the musculoskeletal system; (3) requires compliance by the patient that can easily be achieved (three times five to ten minutes treatment, usually once a week); (4) can be fully performed on an outpatient basis; (5) can be combined with other PRM treatments; (6) No medication; and (7) Gentle and effective [12-14]. Contraindications of ESWT are treatment over air-filled tissue (lung, gut), tissue with local tumors or local bacterial and/or viral infections, pre-ruptured tendons, pregnant women, patients under the age of 18 (except of the treatment of Osgood-Schlatter), patients with blood-clotting disorders (including local thrombosis), patients treated with oral anticoagulants, patients treated with local cortisone injections [12-14].

High Intensity Laser Therapy (HILT) is another one novel therapy for chronic pain. The term laser originated as “light amplification by stimulated emission of radiation.” The basic principle of laser devices are the amplification of electron spin rates by passing photon energy through a particular medium to produce a single directional laser beam having a different wavelength than the original light beam. Recently, high-intensity laser therapy (HILT) is increasing evidences. The privilege of HILT over Low Laser Light Therapy (LLLT) is able to reach and stimulate the large and/or deep joint [23,24]. Previous studies describe the anti-inflammatory, anti-edematous, and analgesic effects of HILT [23,24]. It has been used to provide relief from the symptoms of shoulder pain [23], chronic ankle pain [24], and low back pain [25]. In the present study, HILT results were superior to those of LLLT in pain relief and improvement of function.

This is supported by the belief that the effect of laser, which can alter cellular and tissue function [25].

Ultrasound guidance nerves block is another novel intervention which increasing practices and evidences in diagnosis of facet joint pain. Therapeutic blocks with only local anesthetics (greater occipital nerve and sphenopalatine ganglion) are effective in headache, whereas their efficacy for other chronic pain conditions have not been adequately [26-28].

Introducing the functional context of movement early in musculoskeletal rehabilitation may lead to greater movement gains and earlier cortical recovery, as CNS changes are greater with task specific training [29-31]. Repetitive movement can induce cortical changes such as the use of shoulder taping to facilitate pain-free repeated use of upper limbs during functional tasks throughout the day. When pain prevents a patient from performing movements, physical repetitions may be too limited to induce neuroplasticity changes and mental imagery may be used. These novel treatments being used in musculoskeletal rehabilitation will induce CNS plasticity [29,32].

Diagnostic ultrasonography (US) has shown promising results to identify and differentiate musculoskeletal pain. Diagnostic US has recently been used to identify trigger points because of its ability to characterize viscoelastic properties of myofascial tissue and identify high resistance arterial flow at trigger point sites [33-35].

In conclusion, novel approaches in chronic pain could be of any individual treatment. The underlying neurophysiological mechanisms that enhance the adaptive sensorimotor changes associated with musculoskeletal dysfunction are essential part in clinical practice. Novel of Desensitization techniques and the potential for neuroplasticity with specific interventions are well evidences support.

Conflicts of Interest

The author declares no conflicts of interest.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 8096
  • [From(publication date):
    August-2016 - Mar 30, 2017]
  • Breakdown by view type
  • HTML page views : 8042
  • PDF downloads :54
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version